Supernus Pharmaceuticals (SUPN) Debt Ratio (2011 - 2025)

Supernus Pharmaceuticals (SUPN) has 9 years of Debt Ratio data on file, last reported at 0.02 in Q4 2025.

• On a quarterly basis, Debt Ratio fell 38.23% year-over-year to 0.02 in Q4 2025; TTM through Dec 2025 was 0.02, a 38.23% decrease from a year earlier, with the FY2025 full-year figure at 0.02, down 38.23% from the prior year.
• Debt Ratio for Q4 2025 stood at 0.02, up from 0.01 in the prior quarter.
• Over the last five years, Debt Ratio for SUPN reached as high as 0.25 in Q4 2021 and fell as low as 0.01 in Q3 2025.
• Historically, Debt Ratio has averaged 0.04 across 5 years, with a median of 0.03 in 2022.
• Across the five-year window, Debt Ratio soared 1122.11% in 2021 and plunged 95.06% in 2022, its largest moves.
• Year by year, Debt Ratio stood at 0.25 in 2021, then tumbled by 95.06% to 0.01 in 2022, then surged by 228.52% to 0.04 in 2023, then decreased by 15.09% to 0.03 in 2024, then sank by 38.23% to 0.02 in 2025.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.02 in Q4 2025, 0.01 in Q3 2025, and 0.02 in Q1 2025.